CARE1 Pragmatic Clinical Trial

Conditions: Metastatic Kidney Cancer; Metastatic Kidney Carcinoma Interventions: Drug: Nivolumab; Drug: Ipilimumab; Drug: Pembrolizumab; Drug: Cabozantinib; Drug: Axitinib; Drug: Lenvatinib Sponsors: Gustave Roussy, Cancer Campus, Grand Paris; European Commission; CRIS Cancer Foundation; National Cancer Institute, France; Rennes University Hospital; University Hospital, Essen; Fundaci ó Privada Institut d ' Investigaci ó Oncològica de Vall d ' Hebron; The Netherlands Cancer Institute; Servicio Madrile ño de Salud, Madrid, Spain; Hospital Universitario 12 de Octubre; Fondazione IRCCS Istituto Nazionale dei Tumori, Milano; Medical University of Vienna; FAKULTNI NEMOCNICE OLOMOUC; International Kidney Cancer Coalition; Association pour la Recherche sur les Tumeurs du Rein; Resilience; PRIMAA; Queen Mary University of London Not yet recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials